Therapeutical combination against cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 4, 2006
Grant Date -
May 5, 2005
app pub date -
Oct 30, 2003
filing date -
Oct 30, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either .beta.-(1,3)-glucan like laminarin or a oligo-.beta.-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully